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Abstract
Cystic echinococcosis (CE) is an infectious disease caused 
by the larvae of parasite Echinococcus granulosus  (E. 
granulosus ). To successfully establish an infection, 
parasite release some substances and molecules that can 
modulate host immune functions, stimulating a strong 
anti-inflammatory reaction to carry favor to host and 
to reserve self-survival in the host. The literature was 
reviewed using MEDLINE, and an open access search for 
immunology of hydatidosis was performed. Accumulating 
data from animal experiments and human studies 
provided us with exciting insights into the mechanisms 
involved that affect all parts of immunity. In this review 
we used the existing scientific data and discuss how 
these findings assisted with a better understanding of the 
immunology of E. granulosus  infection in man. The aim 
of this study is to point the several facts that challenge 
immune and autoimmune responses to protect E. 
granulosus  from elimination and to minimize host severe 
pathology. Understanding the immune mechanisms 
of E. granulosus  infection in an intermediate human 
host will provide, we believe, a more useful treatment 
with immunomodulating molecules and possibly better 
protection from parasitic infections.  Besides that, the 
diagnosis of CE has improved due to the application 
of a new molecular tool for parasite identification by 
using of new recombinant antigens and immunogenic 
peptides. More studies for the better understanding of 
the mechanisms of parasite immune evasion is necessary. 
It will enable a novel approach in protection, detection 
and improving of the host inflammatory responses. In 
contrast, according to the “hygiene hypothesis”, clinical 
applications that decrease the incidence of infection in 
developed countries and recently in developing countries 
are at the origin of the increasing incidence of both allergic 
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and autoimmune diseases. Thus, an understanding of 
the immune mechanisms of E. granulosus  infection is 
extremely important.
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Core tip: The most common location of a hydatid echino-
coccal cyst is in the liver. The survival of Echinococcus 
within host tissues, despite the development of specific 
antibodies, is possible due to specific immunomodulation 
induced by parasites. Perpetual survival of parasites 
indicating multi-level systematic evasion against host 
protective reaction to persist their growth and spreading. 
Complement modulation, a metabolic adaptation to 
the host microenvironment, plentiful thermostable 
immunogenic antigen B in the cystic fluid, and induction 
of CD4+CD8+FOXP3+ T cells allows the persistence of 
the parasites. Parasites influence dendritic cell (DC) 
maturation and impair activation by toll-like receptor. It 
seems that DC-parasite interaction is pivotal in triggering 
and regulating parasite induced immunity.
Grubor NM, Jovanova-Nesic KD, Shoenfeld Y. Liver cystic 
echinococcosis and human host immune and autoimmune follow-
up: A review. World J Hepatol 2017; 9(30): 1176-1189  Available 
from: URL: http://www.wjgnet.com/1948-5182/full/v9/i30/1176.
htm  DOI: http://dx.doi.org/10.4254/wjh.v9.i30.1176
INTRODUCTION
The dog tapeworm Echinococcus granulosus (E. gran­
ulosus) is the main challenger of a global parasitic 
zoonosis cystic echinococcosis (CE) in humans caused 
by the larvae from the infected dog[1]. After incidental 
ingestion the larvae of parasite, the oncosphere/exacanth 
larvae is releasing from the keratinized embryophore 
in the stomach and intestine of the intermediate host 
(herbivores or humans). Embriophores in the intestine 
of man via hook movements penetrate into the small 
intestine of host. Its life cycle develops in dogs and other 
canids (wolves, foxes, coyotes, jakals) that harbor the 
adult tapeworm. The larval metacestode form develops 
in different organs of the intermediate host[2]. Hydatid 
cyst is mainly located in the liver (70%) or lungs (20%), 
but occasionally they may find their way to other organs 
(kidney 2%, spleen 2% and brain less than 2%)[3]. In 
the intermediate host the eggs cross intestinal wall and 
develop into larvae. The oncosphere is then carried 
out via portal vein flow into the liver and other organs. 
There oncospheres undergoes a metamorphosis towards 
the metacestodes. The metacestodes implant into the 
organ and grow into cysts, with all characteristic layers: 
Germinal, outer and laminated (Figure 1)[4,5]. Organs 
may also be reached through the lymphatic system[6]. 
Echinococcal cysts is surrounded by pericyst (adventia) 
from the periparasitic host tissue, which surround the 
larval endocyst (Figure 1A and B). The endocyst is also 
composed of a cuticular or laminal acellular outer layer 
and an inner germinal proligerous, which gives rise in a 
fertile cyst to root capsules and protoscoleces (PSCs)[7]. 
Some cysts may also harbor daughter cysts of variable 
sizes (arrows in Figure 1C). Cysts also contain developing 
PSCs, which constitute an infectious agent. PSC is 
developing into the adult tapeworm if will be ingested 
by a suitable definitive host (sheep, cattle, goat). Some 
vesicles adhere to the walls by means of a peduncle or 
remain free within the hydatid fluid. A large number of 
these vesicles (endogenous daughter vesicles) and free 
protoscoleces float in the hydatid fluid, together forming 
the co-called “hydatid sand”. New offspring vesicles in 
the hydatid fluid play the same role and have the same 
constitution of the vesicle mother. The hydatic liquid is 
clean and clear. It contain all secreted molecules from 
parasite and host, which is very similar even identical to 
that of the host’s serum containing Na, K, Cl, and CO2), 
a density between 1.008 and 1.015, and alkaline pH[8]. 
Thus, in this way, protoscoleces may develop into either a 
new cyst or in adult parasite. As the cyst later becomes a 
successful xenograft in the host, it progressively enlarges 
until symptoms or complications appear[9,10]. Therefore, 
the clinical manifestation of infected humans with E. gra­
nulosus, could be expressed from asymptomatic infection 
to severe, potentially fatal disease. The parasite die due 
to dysfunction of germinal membrane (detached, aging 
or micrortaumatisms) but the scolex may transform into 
vesicle trying to preserve the species[11].
The survival of Echinococcus within the host tissues, 
despite the development of specific antibodies (Abs), 
is possibly the result of specific immunomodulation 
induced by the parasite[12]. This phenomenon has been 
the subject of study by many researchers during the 
last two decades. They aimed to investigate the host 
responses to the parasite. The final goal of the present 
study was to review these modifications of the immune 
and autoimmune responses induced by E. granulosus. 
For better understanding of host-parasite interactions in 
this review human clinical study used complementary 
to animal studies. However, although some of the 
mutual interactions between parasite and human host 
in infection have been resolved, essence of protective 
mechanisms of human host are still unclear.
IMMUNE RESPONSE TO E. GRANULOSUS 
INFECTION OF THE HOST
Effects on innate immunity
Almost exclusively within the intermediate host’s liver, 
parasitic metacestode vesicles grow infiltratively, very 
similar to that of malignant tumor. The host immune 
system reacts to these formations. But there is no data of 
granulosis-induced immune suppression in echinococcosis 
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on the molecular and cellular level, particularly in the early stages of the infection. On the other hand, there is 
Embrionated eggs
In feces of end host
Th1→IFN-γ and IL-12 (Rigano et al , 1999; Siracusano et al , 2012)
Oncospheres
Hatches and penetrates intestinal wall of intermediate host
Metamorphosis; IgE and basophils (Aceti et al , 1990; 1992)
Th2: IL-4; IL-5; IL-10; TGFβ-(Amri et al , 2009) - susceptible to the parasite
Metacestodes
growth infiltratively
DC underwent apoptosis and survived DC failed to mature (Evert et al , 2010)
Consumption of complement (Diaz et al , 1995; Ferreira et al , 1995)
Induction of CD4+CD25+Foxp3+ (Bennett et al , 2001) → fulfill an important role for parasite survival
Liver cyst
Antigen B from hydatic cist fluid influence parasite survival
(1) Suppresses human neutrophil chemotaxis (Shepherd et al , 1999; Rigano et al , 2001)
(2) Inhibits lipid detoxification and metabolism by fatty acid binding property (Chemale et al , 2001; 2005)
(2) Modulates dendritic cells maturation (Ortona et al , 2001)
(4) Influences innate and adaptive host immunity
(5) Suppresses IL-12p70, but not and IL-6 (Zhang and McManus, 2003)
(6) Increases IL-10→Th2 (Amri et al , 2009)
(7) Increases IL-10→Th2 (Amri et al , 2009)
(8) Inducts a new heat shock protein- HSP70 (Ortona et al , 2003)
Protoscolex
from cyst 
→ 12 kDa - serin protease inhibitor with strong chemoattractant activity
→ Activate PMN-Le, Ne, basophils and mast cells to protoscolex inducing inflammation
→ Allowing Protoscolex to develop into secondary cyst (Rigano et al , 1996; Karavia et al , 1996).
→ Activate alternative complement pathways (Ferreira et al , 1996)
→ →IgG and Ag-Ab interactions may induce apoptosis
→ Cyst infertility (Peredes et al , 2011) 
→ Activate CD8+T lymphocytes (Kizaki et al , 1993)
→ Upregulate maturation markers of dendriric cells (Jenne et al , 2001)
AgB:
AgB:
Figure 1  Diagrammatic representation of the development of the Echinococcus granulosus liver cyst. A, B: Liver cystic echinococcosis, our surgical material; C: 
Computed tomography imaging of hepatic cystic echinococcosis; D: Abdominal scan of a female patient with a CE3b cyst in the VI liver segment (adapted from Ref. [120]). 
IL: Interleukin; IFN: Interferon; TGF: Transforming growth factor; PSC: Protoscolece; PMN: Polymorphonuclear.
Daughter cyst
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no doubt that the defensive immune reaction is missing 
and parasite survive. Future survival of parasites indicates 
that they have developed some mechanisms of evasion 
from host protective immune mechanisms to preserve 
their expansion[13]. Many studies in humans and mice 
showed that after parasite infections at the beginning 
dominates T helper 1 (Th1) immune responses (Figure 
2). Th1 immune responses is characterized by the release 
of interferon-γ (IFN-γ) and after priming by dendritic 
cells (DCs) with IL-12[11,14]. Both are effective in the 
elimination of the parasite at an early stage. However, 
it has become clear that the parasite, probably by its 
excretory/secretory products, actively influences the host 
immune response, leading it to the Th2 response and 
parasite survival. Namely, the Th2 cytokine profile of IL-4, 
IL-5, immunosuppressive IL-10 and transforming growth 
factor beta (TGF-β) are generally associated with receptive 
capability of the parasite that leading to progressive 
disease (https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC3283565/ - pntd.0001516-Vuitton1)[15]. On the other 
hand, the polymorphonuclear (PMN) leukocyte, basophil-
mast cell and monocyte participation showed intense 
local inflammatory reaction to protoscoleces (PSCs)[16]. 
Significant increases in the chemiluminescence response, 
superoxide (O2) production and phagocyte index have 
been detected in patients with dead cysts compared 
with healthy subjects, whereas a marked reduction in 
all the above markers was observed in patients with 
liver cysts[17]. Functionally and metabolically the PMN 
leukocytes of infected patients are in an activated state[18]. 
Regarding basophils, the human basophil degranulation 
test was found to be positive in 33% of patients with 
hydatid disease (HD)[19]. Furthermore, evidence of 
increased histamine release from hydatid patient basophils 
following a challenge with anti-human IgE has also been 
obtained[20]. It can be concluded that both the generation 
of histamine releasing factor (HiRF) and production of 
IgE, which can bind cytokines, may be involved in this 
stage of infection[21]. This histamine releasing factor was 
found to activate basophils through surface-bound IgE, 
cytokine production and Th2 cell activation[16,21-23]. Method 
of antibody-dependent cell-mediated cytotoxicity is well 
established as an important mechanism by which the 
host can damage a multicellular parasite, but why it is not 
happening?
Additionally, it is well known that the surface of 
many parasitic helminths, including E. granulosus, is 
able to activate the alternative pathway of the com-
plement system[24,25]. Although the complement can 
lyse protoscoleces of E. granulosus, parasite with 
some secretion products could be able to consume the 
complement, which is an ability that has been proposed 
as the basis of an invasion mechanism by the parasite[25]. 
However, the levels of component 3 of complement and 
chemolitic complement in mice showed no evidence of 
complement consumption[25]. Moreover, C3 levels were 
significantly increased in patients with hydatid disease 
compared to controls[16,26]. Thus, it is possible that local 
consumption at the site of infection may exist, leading to 
systemic consumption in the more active cysts. Finally, 
the existence of several mechanisms of complement 
modulation was found when comparing complement 
activation in vitro by different E. granulosus extracts[27]. 
These findings further enhanced the possibility of their 
significant role in the susceptibility of infection and/or 
maintenance of the disease. 
The parasite must be able to adapt metabolically to 
the host microenvironment, and antigen B (AgB) could 
be involved in this process. The termostabile AgB (166 
kDa) resists boiling for 15 min without losing antigenicity. 
Thus, AgB proteins as highly immunogenic acts directly to 
innate and adaptive immunity. Additionally, many antigen 
B (AgB) molecules in the hydatid cyst fluid possibly 
guarantee parasite survival. The gene family of AgB 
comprising at least 10 unique genes in five subclasses 
differentialy expressed in its life cycle, except EgAgB3 
which is expressing predominantly in all cell stages[28,29]. 
Because of their fatty acid binding property, some of 
them are involved in lipid detoxification, transport and 
metabolism[30,31]. Also it is well known that its 12 kDa 
unit is able to inhibit human neutrophil chemotaxis[32,33]. 
This unit is a serine protease inhibitor with strong 
chemoattractant activity. This is a reason for released 
protoscoleces to develop into secondary cysts[10]. Co-
incubated with Echinococcus primary cells, AgB functioning 
similar to invading oncosphere or metacestode vesicles. 
In these conditions, some dendritic cells (DCs) dead, 
and the survived fail to mature[34]. But, DCs exposed 
to protoscoleces up-regulated maturation markers and 
stay functional. Pre-incubation with primary cells and 
metacestode vesicles, impaired ability of DCs to be 
activated by the Tall-like receptor  ligand LPS. This was not 
observed in those pre-treated with protoscolex excretory/
secretory products[35]. The induction of CD4+CD25+Foxp3+ 
T cells to metacestode E/S-products suggests that 
these cells play important role for parasite survival. The 
immunomodulatory products from parasites are therefore 
of high interest for understanding by infections induced 
immune pathology and treatment of allergy. 
E. GRANULOSUS EVASION 
MECHANISMS IN THE HOST
Characterization of molecules involved in evasion 
In intermediate hosts, protoscoleces develop exclusively 
in fertile cysts. This formation also consists all of three 
membranes (inner cellular, other glicin rich and laminated 
acellular)[36]. Nevertheles, E. granulosus cystic form can 
induce IgG that is able to cross the tegument and plasma 
membranes between laminar and germinal layers of the 
cyst. On the other side, method of antibody-dependent 
cell-mediated cytotoxicity is well established as an 
important mechanism by which the host can damage a 
multicellular parasite. There IgG recognize specific cystic 
antigens, and antigen-antibody complex may inhibit 
proliferative process of protoscoleces, but why it is not 
happening? Due to germinal layer of the cyst is a barrier 
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for immune competent cells of the host[36]. Except this 
the parasite evolving other immune evasion strategies[37]. 
E. granulosus using two main mechanisms to undermine 
the host immune response: First is passive escape, in 
which during the development of hydatid cyst, parasites 
avoids the damaging effects of host immune reaction; 
and second is immunomodulation, in which the parasite 
is actively included in the immune reaction to trigger the 
host’s profit[38,39]. 
Circulating antibodies as immunological markers in CE
Although patients with hydatidosis releasing amount 
of circulating IgG, IgM, IgA and IgE antibodies (Abs) 
to E. granulosus, no one is associated with the host 
protection[40]. IgG4 in echinococcosis is not able to 
complement fixation neither is cytophilic, also weekly 
binding to Fc fragment of immunoglobulins, then is not 
functional. All of these will support the parasite evasion of 
host immune response[41]. Even, parasite-specific IgG4 
antibodies by inhibiting IgE mediated degranulation of 
effector cells, reducing allergic pathology in the host to 
prolong parasite survival[42]. In agreement with this study 
are findings that significantly lower levels of serum IgG4 
antibodies  is detected in albendazole-treated patients 
who exhibited a good therapeutic and clinical response 
compared to that in poor responders or non-responders. 
Additionally, data obtained in various countries showed 
reverse trend of IgG1 levels[40,42]. Beside that patients 
showing differences in IgG1 expression. Those without 
allergic manifestations releasing IgG4 antibodies specific 
to EA21, whereas patients with allergic manifestations 
showed IgE specific to the same antigen. Authors 
have suggested that CE IgG4 obviously work to block 
pathogenic processes and to, minimize severe pathology 
in the host providing parasite survival[42] (Figure 2). 
Antigen B and other new antigens in immunomodulation
In CE characterized with Th2 polarized microenvironment, 
besides AgB, EgTeg and EgEF-1 β/δ, several other parasite 
molecules can elicit this phenotype. More sophisticated 
Physical barrier Immune evasion
Parasitic IgG4 can inhibit IgE mediated degranulation of effector cells and by reducing of allergic pathology, 
prolonging the parasite survival (Yazdanbachsh et al , 2002)  
IgG4 and IgE to EA21 and cyclophilin (allergen) also can reduce severe pathology (Ortona et al , 2002)
EgAgs: AgB; Egteg; EgEF-1β/δ; Eg2ASP70 (Ortona et al , 2001; 2002; 2003)
AgB: modulate DC maturation and suppress Il-12p70, but not IL-6 (Elliot et al , 2009)
EgEF-1β/δ; Eg2ASP70: As allergic tarrgets prolonging parasite survival (Ortona et al , 2001; 2002; 2003)
> IL-10 by activation of B cells favor polarizing Th phenotype (Baz et al , 2006) 
Th1 and Th2 are not
precommitted phenotype
(Jankovic et al , 2006)
They are endpoints of multistep differentiation
process acquiring different cytokine secretion
(Amri et al , 2009)
< Th1
> Th2
(Rigano et al , 1999; 2004; 2007)
DC - parasite interaction
Triggering parasite-induced immunity by
  Influence Th1 to Th2 shift
  DC fail to mature in the presence of crude non-fractional parasite in intermediate host









> IFN-γ < IL-4






Inactive cyst Active cyst
Mixed clone: Th1; Th2 and Th0
Figure 2  Subversive strategies of Echinococcus granulosus. DC: Dendritic cell; IL: Interleukin; IFN: Interferon; TGF: Transforming growth factor.
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approach such as proteomic pronounce the presence 
of a large number of antigenic proteins associated with 
parasites. Antigen B (AgB) modulates DC maturation 
and suppresses IL-12p70, but not IL-6 release[43]. As 
allergic targets in CE in acute cutaneous allergic mani-
festation, three conserved constitutive proteins at a 
molecular level have been identified: EgEF-1 β/δ, EA21 
and Eg2ASP70[44-47]. At least two of three appear to have 
immune modulatory properties. EgEF-1 β/δ influences 
immune modulation and is released after the death 
or degeneration of protoscoleces[45]. Furthermore, 
appearance of CD4+CD25+Foxp3+ T cells in excretory/
secretory products of metacestode suggests that 
these cells play important role in survival of parasite in 
chronic echinococcosis[35,48]. The secretory and excretory 
products of parasite helminthes are therefore extremely 
important for better understanding of immunopathology 
of parasite infection and for allergy treatment as well. 
Future immunological studies will give us opportunity to 
investigate their role and immunomodulatory effects on 
parasite infections in humans. However, the long- time 
(years) development of CE highlights the difficulty in 
understanding the host-parasite relationship[49,50]. More 
investigations are necessary for integration of these 
studies with previous obtained results to recognize and 
understand well the extreme complexity of the host-
parasite interactions. These findings are extremely 
important for the development and improvement of CE 
diagnosis and treatment. Finally, it is indispensable for 
control strategies and vaccine development.
Immunomodulation by cytokine production
Plasticity of both the nature and magnitude of immune 
host responses depend on infective agents that permit the 
immune system to tailor its defense strategy. Th1 and Th2 
cells are not pre-committed cells with defined phenotype, 
their phenotype is result of a multistep differentiation 
process, thus a precursor population acquires secretion 
of different cytokines profiles[47]. How E. granulosus 
antigens (Ags) encountering the human immune system 
can influence the differentiation decision in human 
echinococcosis? First of all it is well known that the immune 
response established in E. granulosus infection is mainly 
of Th2-phenotype. Also E. granulosus antigens modulate 
polarized T-cells (Figure 2). Furthermore, increased level 
of IgG4 and IgE antibodies and induced eosinophilia 
supporting assertion that the immune response established 
in E. granulosus infection is Th2-dominated. Findings from 
experimental echinococcosis confirm the hypothesis that 
early IL-10, secreted by B cells in response to mitogens, 
may favor parasitic survival by established type-2 cytokine 
response[50]. There are many evidence of molecular studies 
where reciprocity of IL-4/IL-10 is that impairs the Th1 
protective response allowing the parasite survival in human 
host[51]. In addition, patients responsive to albendazole 
in peripheral blood monocyte cells (PBMCs) showed 
high amounts of IFN-γ (Th1-derived), whereas PBMCs 
from patients who did not respond to albendazol therapy 
produced a higher level of IL-4 and IL-10 (Th2 derived)[14]. 
These findings are in coordination with a molecular studies 
that detected IL-12p40 mRNA in 86% of successfully 
albendazole-treated patients at the end of chemotherapy 
who expressed a high level of IFN-γ and TNF-α DNA[15,52]. 
Finally, patient with an inactive cyst expressing Th1 
phenotype, while patients with active and transitional cysts 
showed mixed Th1/Th2 and Th0 phenotype[53]. No IL-5 and 
scarce IL-4 and IL-10 is detected in seronegative patients[54]. 
Seronegativity occurs due to the host or parasite factors 
or both preclude the possibility of Th2 cell activation that 
limiting the production of IL-5, crucial for immunoglobulin 
expression.
It has been shown recently that bone marrow-de-
rived dendritic cells (DCs) from non-lymphoid tissues 
show capability for antigen presentation and antigen 
processing[55]. Also there are findings that inflammatory 
mediators or microbial agents promote the migration 
of DCs into the lymph nodes and other secondary 
lymphoid organs. By maturation, DCs lose their ability 
for antigen presentation and gain an increased capability 
to prime T-cells[56]. Thus, it is no doubt that DC-parasite 
interactions are very important for triggering and 
regulation of parasite-induced immunity. On the other 
side, E. granulosus cystic fluid modulates differentiation 
and cytokine secretion of dendritic cells[57]. Finally, these 
cellular findings established that E. granulosus except 
for modulation of DC maturation is included in the 
polarization of T lymphocytes toward Th2 phenotype[58,59].
ADAPTIVE IMMUNITY
Role of dendritic cells in parasite evasion
Dendritic cells (DCs) as an antigen presenting cells, no 
doubt represent a link between innate and adaptive 
immune systems. They are inducing immune responses 
with Th1, Th2 or Th17-dominated phenotype (https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC3283565/ - pntd. 
0001516-Everts1)[60]. After contact with parasite, DCs take 
up the recognized antigens and undergo maturation in the 
presence of up regulated MHC/HLA mice/man) complex 
and co-stimulatory molecules CD86 and CD80[34,60]. 
Nevertheless, after migration in the lymph nodes, DCs 
interact with naïve T cells to promote adaptive immune 
responses with Th1, Th2, and Th17 cell phenotype 
(https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283565/ 
- pntd.0001516-Banchereau1)[61,62]. There by activation 
of T regulatory cells, DCs becoming targets for parasite 
evasion. Mejri et al[63] showed that peritoneal DCs from 
chronically infected mice, representing the late stage of 
alveolar echinococcosis. The same authors have reported 
that DCs in infected mice specifically modulates CD4+ and 
CD8+ T cell responses, suggesting their immunosuppressive 
T regulatory function in echinococcosis[63]. In intermediate 
host parasitic larvae migrate from the intestinal entry site to 
the liver and late metastasis to other organs (lung, kidney, 
spleen or brain)[64]. This finding suggest that parasitic 
larvae encounter DCs in vivo[64]. Despite the general 
importance of DCs in cellular host-parasite interaction, 
immunomodulatory molecules that are released by 
Grubor NM et al . Liver cystic echinococcosis and immunity
1182 October 28, 2017|Volume 9|Issue 30|WJH|www.wjgnet.com
Echinococcus larvae and have an influence on DC function, 
are still not characterized. Compared to other helminthic 
infections, immunomodulatory functions of DCs in E. 
granulosus infection in human host provided less attention, 
although this is an emerging and important field[65]. In two 
reports, Reyes et al[66] and Terrazas et al[67] investigated the 
effects of excretory/secretory products of Taenia crassiceps 
cysticerci on the activation of murine DCs, representing 
the metacestode larval stage of by Taenia infection. DC of 
susceptible mouse strain when preincubated with parasite 
excretory/secretory product, authors showed decreased 
DC maturation because of impaired susceptibility to TLR-
dependent stimulus[66,67]. Whether these interactions are 
relevant in vivo is not clear. First of all due to the spectrum 
of protein products from metacestode excretion and 
secretion does not necessary overlap the spectrum of 
proteins in the hydatid cyst fluid[68]. For example, AgB is not 
detected in excreted or secreted products in vitro cultivated 
metacestode vesicles, but this component is well expressed 
in hydatic cystic fluid[69]. Second, the intact parasite tissue 
is showed usually prevents direct contact between hydatid 
cystic fluid and host immune effector cells. Dendritic cells 
react with unfractionated helminthic proteins generating 
anti-parasitic cytotoxic T lymphocyte[70]. Thus, crude 
methods of in vitro preparation of metacestode antigen, 
insufficient purified which contain vesicle fluid somatic 
parasite proteins and contaminating host components, 
tested concerning their effects on DCs, failed to induce 
maturation as did a purified mucin-type glycoprotein (Em2) 
that is usually expressing at the surface of LL-containing 
metacestode vesicles (https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC3283565/ - pntd.0001516-Hlsmeier1)[71,72]. 
However, it is well known that extrinsically triggered 
infectious with viruses, bacteria and parasites, usually results 
in a bystander effect of induced immunosuppression[73]. 
Bystander effects of parasite-induced 
immunosuppression
Dendritic cell apoptosis induction has been reported in 
nematodes in which their capacity for releasing of pro-
inflammatory IL-12 is limited and that prevents activation 
and proliferation of T cells[74]. Different from others 
investigator accept the possibility that the diminished 
function of DCs in metacestode infection is by induction of 
apoptosis of immature cells rather than due to inhibition 
of its maturation. It could be a reason for establishing of 
an immunosuppressive environment around the parasite 
lesions. Transforming growth factor beta (TBF-β) signaling 
is involved very early in this process because in animal 
evolution they are expressed very early in all invertebrate. 
Therefore, it is understandable that diminished ability of 
DCs pre-incubated with excretory/secretory-products 
of primary cells in metacestode is indirectly mediated 
by the induction of apoptosis of immature DCs, rather 
than by direct inhibition of DC maturation. Imature DCs 
secrete TGF-β, which induces differentiation of naïve T 
cells into FOXP3+ T-regulatory cells, and subsequently 
immunosuppression around the parasite lesion[73]. TGF-β 
signaling is involved very early in animal evolution, thus 
TGF like cytokines are expressed very early in many 
invertebrate, and in parasites as well[75,76]. 
Different from DCs incubated with primary cells of 
metacestode vesicles, those exposed to E/S products of 
protoscoleces showed up-regulation of surface markers 
MHC-Ⅱ and CD86, increased secretion of IL-6, but not 
IL-10 and impaired ability of DCs to produce IL-12 by 
tall-like receptor lipopolisacharides (LPS) stimulated[74].
Presented phenotypes are similar to that obtained 
when DCs are incubated with E. granulosus hydatid cyst 
fluid (HCF), and with isolated AgB[55,59].
In contrast to these investigations, DCs incubated with 
protoscolex compounds as presented in their study Rigano 
et al[55], 2007 and Kanan and Chain[59], 2006, dendritic cells 
did not release elevated levels of IL-10 or IL-12 (https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC3283565/ - pntd. 
0001516-Kanan1). Presented phenotypes are similar to 
the obtained when DCs are incubated with E. granulossus 
hydatid cyst fluid (HCF) and with its isolated AgB. It seems 
that only protoscoleces weakly expressing AgB[30,77]. Finally, 
DCs phenotype upon co-incubation with E/S-products of 
protoscoleces is largely comparable with those incubated 
with certain Trypanosoma antigens, closely associated with 
the induction of Th2 immune response[78]. The differences 
obtained between the responses of DCs to E/S-products of 
early versus late developmental stages of E. multilocularis 
clearly demonstrates that an induction of tolerance of DCs 
is not a general characteristic of Echinococcus material. It is 
the results of excretory and secretory repertoire of primary 
cells. Metacestodes are specifically evolved to carry out 
these purposes[79]. The interpretation of obtained results 
concerning the immune response in echinococcosis by 
using of in vitro co-incubation-systems of Echinococcus 
protoscoleces with host cells[80-86] or in the mouse model of 
peritoneal, protoscoleces, should be presented very careful, 
because of not to provoke suspicious of their verification[87]. 
The oncosphere that undergo as metamorphosis toward 
metacestode could induce impaired response of IL-10 
secreting DCs in vitro[87]. These findings suggests that 
similar mechanisms might also further investigation by 
methods of primary cells could resolve the nature of 
echinococcal products responsible for these effects. But the 
effects at the begining of infection with E. granulosus and 
that in chronic phases have not the same nature. They 
are late reduced, and leading to disappearence of FOXP3+-
T-reg from microenvironment and decreased number 
of immature DCs in protoscolex stage. Beside that the 
results are concentrated about in vitro interactions between 
parasite larvaes and DCs in response to primary cells. No 
doubt that similar mechanisms operate in surrounding 
tissue in response to primary cells. This process might 
be important for early establishment of the parasite due 
to higher vulnerability of the host immune system. Later, 
after production of the laminar layer (LL) and activation 
of Treg cells, a slightly altered profile of excreted/secreted 
products could support long-term persistence and growth 
of the metacestode (https://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3283565/ - pntd.0001516-Mejri1)[88]. 
Future investigations by using of genome sequence infor-
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mation[5,89], and other  genetic manipulation of primary 
cells[90], will give us opportunity for better understanding of 
the molecular mechanisms of parasite-host interactions.
CE AND AUTOIMMUNITY
Genetic predisposition in combination to others environ-
mental factors have a decisive role in the induction of 
autoimmune reactions to E. granulosus and others parasitic 
infections. Genetically predisposed person with defective 
regulation of immune functions could be more receptive 
for autoimmune follow-up after parasite infections. A 
combination of autoimmunity environmental triggers and 
genetic factors can lead to immune imbalance and could 
influence the appearance of autoimmune diseases (Figure 
3). CE and others parasitic disorders at their source will 
request the answer on question, why in some persons 
abnormal immune reactions arise more extensively than 
in others infected with the same parasite?  To answer 
this question understanding of intrinsic mechanisms 
responsible for immune suppression need to be resolved. 
The well-known part of this mechanism is uncontrolled 
synthesis and elimination of self-reactive lymphocytes. 
Patients with CE showed increased number of T regulatory 
(Treg) cells, related cytokines such as IL-17 and IL-23, 
transcription factor FOXP3 and TGFβ-1 level compared to 
control healthy subjects[91]. The Th17/Treg balance controls 
inflammation and thus may play an important role in the 
pathogenesis of immune evasion[91]. To estimate damage 
of this disbalance, Rosenblum et al[92] (2015) detected 
Th17/Treg functions at different levels of immune reaction 
by analyzing the cell frequencies,  related cytokine 
secretions and key transcription factors in CE (Figure 3). 
Findings showed that a Th17/Treg functional disbalance 
in patients with chronic CE, suggesting a potential role for 
a Th17/Treg imbalance in the pathogenesis and immune 
evasion of E. granulosus. Regarding to genes associated 
with autoimmune diseases, the strongest associations 
with HLA alleles were detected[93]. But, there are no 
data how different HLA alleles facilitate any autoimmune 
disease. Bearing in mind that many HLA alleles are 
capable to present self-antigens in healthy and in infected 
subjects, it is not clear how different HLA alleles influences 
autoimmune diseases. It is unlikely that a disease-
associated allele is especially efficient at displaying the 
autoantigens targeted by self-reactive T cells due to most 
HLA alleles are capable of presenting self-antigens also 
in healthy subjects. Yet, most healthy individuals have 
autoreactive T cells that escape thymic deletion[94,95].
Genetic susceptibility to host autoimmunity
Knowledge of genes that are involved in induction of 
autoimmune diseases are discouraging, and is in lower level 
than those for HLA alleles. Completely different, genetic 
polymorphism of cytokine and cytokine receptors are well 
examined. Findings indicate that cytokines have been linked 
to many different autoimmune diseases, and IL-23 and IL-
23R augmenting inflammatory capability of Th17 cells[94,95]. 
In that way, IL-23R have been discovered in ankylosing 
spondylitis, Behcet’s disease, Crohn’s disease, psoriasis, 
and ulcerative colitis[96]. Moreover, in all of these diseases 
IL-17 positive inflammatory cells have also been associated 
with tissue damage in all mentioned disorders. By using of 
monoclonal antibodies specific for either p40 (a subunit of 
IL-23) or IL-17A their efficacy were confirmed in almost all 
of these disorders[43,97]. Thus, genetic polymorphisms in IL-
23R have in some cases been correlated with responses 
to targeted anti-cytokine therapies. Nevertheless the 
development of many human autoimmune diseases 
is result of reaction of multiple genes involved. There is 
opinion that gene polymorphism is responsible for the 
most human autoimmune diseases. Only a few examples 
existing in which genetic alterations in a single gene result 
in severe autoimmune syndroms. The two best examined 
monogenetic autoimmune syndroms resulting from the 
mutations in AIRE and FOXP3 genes are autoimmune 
polyendocrine syndrome (APS) and immunodysregulation 
polyendocrinopathy enteropathy X-linked (IPEX) syn-
drome[98,99]. These mutations leading to dysfunction in 
central (APS) and peripheral (IPEX) tolerance. Another 
example of autoimmune lymphoproliferative disfunction of 
Fas gene, Fas ligand or of in caspases downstream of Fas 
signaling, resulting in a defective Fas-mediated apoptotosis 
and chronic lymphoproliferative causing lymphadenopathy, 
splenomegaly, and autoimmune cytopenias[100]. Discovering 
of the single genes responsible for development of afore-
mentioned autoimmune disorders has greatly contribution 
in our understanding of cellular and subcellular machanisms 
responsible for the development and follow-up of many by 
parasite induced autoimmune diseases.
Environmental factors in host autoimmunity 
Environmental triggers are factors originating outside of 
the body, such as parasites, bacteria, viruses, toxins and 
medications. No doubt that infections could be important 
triggering factor for autoimmune disfunctions[101,102]. Many 
theories have been created to explain this connection and 
excessive innate/pattern recognition receptor activation 
in autoimmunity. Epitope spreading and antigenic com-
plementary are few between many theories proposed. 
There is evidence that the presence of Epstein bar virus in 
postmortem brain tissue has been linked with appearance 
of Multiple sclerosis (MS), but not with other autoimmune 
inflammatory diseases[103]. Furthermore, peridontal 
infections and rheumatoid arthritis are also linked with 
autoimmunity induced by infection[104]. In contrary, ideas 
existing that infection could protect from some auto-
immune disorders. Thus germ-free mice exposed to 
Bacteroides fragilis could be protected from development 
of experimental autoimmune encephalomyelitis (EAE), by 
induction of Treg cells[105]. In that way, a higher incidence 
of MS and type 1 diabetes in developed countries is 
supposed to correlate with decreased number of in-
fections[106].
Defective regulation as the cause of autoimmunity
The peripheral tolerance to tissue antigens could be 
induced by the low-level of natural cell death through 
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Figure 3  Echinococcus granulosus Induced autoimmunity. Ags: Antigens.
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the tolerance of dendritic cell populations[107]. This 
tolerance of can influence low level of natural cell death 
in the tissue antigens, respectively[107]. If tolerance is the 
main abnormality in autoimmune processes, which kind 
of tolerance is processed in induction of autoimmune 
diseases? In SLE it is maturation of naïve B cells that can 
produce autoantibodies even before encountering with 
antigens. Findings that defects in early B cell tolerance 
checkpoints possible contribute development of an 
autoimmune disease[108]. Beside others, deletion cross 
influences B cell maturation of immature B cells in the 
bone marrow, receptor editing, and the control of mature 
B cells in peripheral tissues[108]. 
Regarding T cell-dependent autoimmunity and inflam-
matory autoimmune diseases, imbalance between 
effector and regulatory T cells play a fundamental role in 
initiation of human autoimmune diseases[109].
Decreased number of functional T regulatory or resi-
stance of effector T cells play decisive role in the initiation 
of autoimmune diseases in human. Obtained results from 
patients with autoimmune disorders are often variable and 
inconsistent, due to the limited assesibility of tissue for 
examination. Even when an optimal number of cells for 
analysis is supplied, in vitro assays that often cannot be 
recapitulated, is not reliable for examination of functional 
capacity in vivo. The disease in autoimmunity might be 
explaned by self-perpetuating ability of autoimmune 
reactions. The self-antigen that drive autoimmune 
reaction remain functional and cannot be eliminated from 
the organism due to the emergency of a new antigenic 
epitopes in damaged tissue and alterations of self-proteins. 
This process is known as antigen epitope spreading 
phenomenon, and a vicious cyrcle is set-up. 
Longitudinal studies of effector and Treg cells that 
are specific for target self-antigens in human disease 
remain a considerable technical challenge. Newly created 
antigenic epitopes activate more different lymphocytes 
in autoimmune reaction, leading to more tissue damage, 
and more novel epitopes to autoreactive lymphocytes. 
In that way, potentiated autoimmune reaction creates 
a new convenient environment for activation of multiple 
immune cells, cytokines and other mediators that 
amplify autoimmune reaction with catastrophic results 
to patient. In that way IFN-I production may induce 
SLE. Then inflammation in SLE showed is involved in the 
propagation of the disease[110]. The prolonged survival 
of E. granulosus metacestodes within the human host 
indicates that some mechanisms are operating to permit 
evasion of the host immune response. Several authors 
tried to describe autoimmune phenomena in patients 
with CE. Autoimmune hemolytic anemia due to IgM cold 
agglutinin with anti-I specificity was found to be induced 
in patients with CE. Moreover, the cleavage fragment 
of C3 has been detected on the erythrocyte membrane 
of a number of CE patients, suggesting that parasitic 
antigens may evoke antibodies that cross with human 
erythrocytes[111]. Furthermore, anti-neutrophil cytoplasmic, 
anti-myeloperoxidase and anti-lactoferrin antibodies 
have also been revealed in the sera of CE patients[112]. 
However, no significant correlations have been observed 
between CE and anti-nuclear antibodies, tissue specific 
autoantibodies and rheumatoid factors. In contrast, 
Aslan and coworkers have measured significant levels of 
antinuclear antibodies, anti-mitochondrial and anti-smooth 
muscle antibodies in patients with CE in comparison 
to age- and sex-matched healthy individuals[113]. Anti-
phospholipid antibodies, anti-cardiolipin antibodies and 
anti-dsDNA have also been shown to be associated 
with several infectious diseases and some autoimmune 
diseases such as systemic lupus erythematosus and anti-
phospholipid syndrome. Such elevated levels of these 
antibodies could be explained by the antigenic mimicry 
between the parasite antigens and host proteins[114]. Since 
cardiolipin and phospholipids are abundant in most cells 
of multicellular organisms, the former is an important 
component of the inner mitochondrial membrane, where 
it constitutes approximately 20% of the total lipid com-
position, while phospholipids are a class of lipids and a 
major component of all cell membranes as they can form 
a lipid bilayer[115,116]. Moreover, autoantibodies class I and 
class Ⅱ MHC gene products have also been demonstrated 
in CE patients, which may contribute to impairment of the 
host immune responses. Chronic and multiple infections 
with viruses, such as Epstein-Barr virus, cytomegalovirus 
and bacteria, such as H. pylori, may also be involved in 
the devolvement of an autoimmune disease in susceptible 
individuals[117].
Finaly, the parasites survive well in the human host 
and the host attempting to destroy them[118]. From a 
promotional perspective, knowledge of immune events 
to response on infection with a helminth parasite could be 
used to reduce the intensity of undesirable inflammatory 
reactions. But, poorly characterized cestode extracts 
cannot help the regulation of human immunocyte function. 
Yet the impact of these for treatment of autoimmune 
or allergic diseases is poorly understood. No doubt that 
helminth parasites are masters for immune evasion and 
regulation. A likely prerequisite for long-term survival is 
outwit of their host’s attempt to eradicate them[119]. 
CONCLUSION
E. granulosus is very complex multicellular parasite. As 
many pathogens is highly immunogenic for human host. 
Thus, the host immunity play a most important role in 
host-parasite relationship in human ehinococcosis. The 
secretory and excretory products  from parasite influences 
immune and immune competent cells in human host and 
stimulate humoral and proinflammatory cell-mediated 
immune responses, releasing of significant antibody 
production, and activate T cells and other antigen-
presenting cells in human host. Thus, the understanding 
of the immune mechanisms is of fundamental importance 
for revealing of a basic protective processes in human 
with hydatidosis. No doubt that protective antibodies 
are also extremely important for development of a new 
more effective vaccines against E. granulosus and other 
parasites. Knowledge of immune events as a response to 
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infection with a helminth parasite could be used to reduce 
the intensity of undesired immune and autoimmune 
reactions such as a variety of auto-inflammatory diseases 
and allergy. Relevant findings is accumulating  showing 
that inflammatory reactions that promote a variety of auto-
inflammatory disease are dampened as a consequence of 
infection with helminth parasites via either the mobilization of 
anti-worm spectrum of immune reactions or direct effects 
of bioactive immunomodulatory molecules and chemical 
compounds released from the parasite. Also the cestode 
extracts are poorly characterized and their impact on 
autoimmune and allergic diseases are not fully examinated 
due to the mechanisms of reaction are not understood. 
Yet issues related to this topics regarding purification 
of immunomodulatory molecules, their site effects and 
action to parasites remains as challenges that need to be 
addressed.
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